project: cardiodx

CardioDX logo

Connect with a Sales Specialist


CardioDx in the News

CardioDx Gains Medicare Coverage for Crucial Coronary Artery Disease Dx

August 08, 2012

Fierce Medical Devices  

CardioDx nailed down reimbursement from a major Medicare contractor for its coronary artery disease blood-based test, a significant and potentially lucrative milestone for the California-based, cardiovascular genomic diagnostics company.

Blood-Based Gene Expression Test Beats MPI for Ruling Out Obstructive CAD

December 14, 2011

Diagnostic and Interventional Cardiology  

The results of the COMPASS (Coronary Obstruction Detection by Molecular Personalized Gene Expression) trial were presented at the American Heart Association Scientific Sessions 2011 conference in Orlando, Fla.

CardioDx Passes Trial, Determining When Chest Pain Is No Big Deal

November 15, 2011


Chest pain is one of the big reasons people go to the ER or to see their primary care doc. Often when people get there, it’s hard to tell who has serious heart disease or something less serious.

Blood test better for coronary arteries

November 15, 2011  

A blood test is more effective to rule out obstructive coronary artery disease than a test that uses a radioactive agent, U.S. researchers say.

Study: Corus CAD demonstrates superiority to MPI

November 15, 2011

Fierce Medical Devices  

CardioDx saw good news from Florida this week with the presentation of results from the COMPASS Study involving Corus CAD, a blood-based gene expression test for obstructive coronary artery disease.

CardioDx fills CFO, chief medical officer posts

September 19, 2011

San Francisco Business Times  

A veteran Bay Area biotech chief financial officer and a former investment bank analyst have joined CardioDx Inc. in senior management jobs.

3 New Medical Tests that Can Save Your Life—But You Have to Ask

June 17, 2011  

A few weeks ago a local politician in my area died of a massive heart attack at 49, while on a lighthearted ski weekend in Tahoe with his buddies.

CardioDx to Use $60M Funding Round to Make Clinical Utility Case for Corus CAD

May 18, 2011

Pharmacogenomics Reporter  

CardioDx has raised $60 million in equity financing that it will invest in expanding reimbursement for its Corus CAD genetic test for coronary artery disease.

Predicting Heart Attacks!

February 07, 2011

Ivanhoe Today  

Every 35 seconds, an America dies of heart disease. If your family has a history of heart attacks or stroke, you are twice as likely to have one yourself.

Medscape Cardiology: A Genetic Test to End Angiography?

January 21, 2011

Medscape Today  

A Best Evidence Interview With Eric J. Topol, MD
A free Medscape account is required to view article.

1 2 3 4 5